Innate Pharma SA (IDD.MU)
Munich - Munich Delayed price. Currency in EUR
Add to watchlist
As of 08:06AM CEST. Market open.
| Previous close | 2.3050 |
| Open | 2.3050 |
| Bid | 2.3400 x N/A |
| Ask | 2.4450 x N/A |
| Day's range | 2.3050 - 2.3050 |
| 52-week range | 2.1500 - 3.4000 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Innate Pharma Highlights Abstracts Selected for EHA 2024 Congress
MARSEILLE, France, May 15, 2024--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") announced today that four abstracts with Innate’s drug candidates have been accepted for the European Association of Hematology (EHA) 2024 Congress, taking place June 13-16, 2024 in Madrid, Spain.
- Business Wire
Innate Pharma Reports First Quarter 2024 Business Update and Financial Results
MARSEILLE, France, May 14, 2024--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today reported its consolidated financial results for the quarter ending March 31, 2024.
- Business Wire
Innate Pharma Announces Conference Call and Webcast for Q1 2024 Business Update
MARSEILLE, France, May 07, 2024--Innate Pharma announces conference call and webcast for Q1 business update
© 2024 Yahoo. All rights reserved.